These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9692689)

  • 1. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice.
    Goves J; Oldring JK; Kerr D; Dallara RG; Roffe EJ; Powell JA; Taylor MD
    Aliment Pharmacol Ther; 1998 Feb; 12(2):147-57. PubMed ID: 9692689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
    Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
    Jones R; Crouch SL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis.
    Bate CM; Griffin SM; Keeling PW; Axon AT; Dronfield MW; Chapman RW; O'Donoghue D; Calam J; Crowe J; Mountfords RA; Watts DA; Taylor MD; Richardson PD
    Aliment Pharmacol Ther; 1996 Aug; 10(4):547-55. PubMed ID: 8853758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
    Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
    Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of alginate and non-alginate antacids concurrently administered with H2 antagonists in cases of duodenal ulcer.
    Chandra M; Gandhi IS
    Br J Clin Pract; 1989 Mar; 43(3):97-101. PubMed ID: 2611119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
    Färkkilä M; Sarna S; Valtonen V; Sipponen P;
    Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
    Chiu CT; Hsu CM; Wang CC; Chang JJ; Sung CM; Lin CJ; Chen LW; Su MY; Chen TH
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1054-64. PubMed ID: 24024757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
    Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
    Ekström P; Carling L; Wetterhus S; Wingren PE; Anker-Hansen O; Lundegårdh G; Thorhallsson E; Unge P
    Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of heartburn symptoms to a new cimetidine/alginate combination compared with an alginic acid/antacid.
    Lennox B; Snell C; Lamb Y
    Br J Clin Pract; 1988 Dec; 42(12):503-5. PubMed ID: 3076786
    [No Abstract]   [Full Text] [Related]  

  • 16. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
    Wilkinson J; Abd-Elaziz K; den Daas I; Wemer J; van Haastert M; Hodgkinson V; Foster M; Coyle C
    Drug Dev Ind Pharm; 2019 Mar; 45(3):430-438. PubMed ID: 30470147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.